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. The reaction also produces dihydrofolate (H 2 fol), which is restored to tetrahydrofolate (H 4 fol) for reuse in catalysis by dihydrofolate reductase (DHFR). TSase is successfully targeted by drugs such as 5-fluorouracil and raltitrexed, and DHFR is the target of methotrexate and trimethoprim.
However, in several human pathogens thymidylate formation is catalyzed by thyX-encoded flavin-dependent thymidylate synthase, or FDTS (EC 2.1.1.148), which carries out the functions of both TSase and DHFR ( Fig. 1) (1, 2) . Many pathogens depend solely on thyX for thymine, including all Rickettsia (causing typhus, spotted fever, and other diseases). Pathogens containing both thyX and thyA, such as Mycobacterium tuberculosis, can synthesize thymidylate through either pathway and often develop multidrug resistance. As multi-and extreme-drug resistance in these pathogens becomes more common, the addition of an FDTS inhibitor to the cocktail could prove essential for treatment. Further information regarding the prevalence of thyX gene in human pathogens, and its potential as a drug target, is provided in the supplementary materials. Hitherto, no drugs are known to selectively inhibit FDTS, and the mechanistic intricacies necessary for the rational design of mechanism-based inhibitors are yet to be resolved. FDTS is genetically and structurally dissimilar not only from the canonical TSase and DHFR but from other flavoenzymes (3, 4) . The current report provides a road map to better understanding of FDTS catalysis and to rational design of inhibitory drugs.
To delineate the mechanism of FDTS catalysis, we report on the trapped reaction intermediates, that is, intermediate species that have been chemically modified by a reaction quencher (here, acid or base). Characterization of these trapped compounds suggested a unique nucleotide methylation path. Our previous report on rapid-quenching experiments with Thermatoga maritima FDTS (TmFDTS) revealed a substantial accumulation of an acid-modified intermediate, identified as 5-hydroxymethyl-dUMP (5). In the current study, we used a basic quencher to stop enzymatic turnover and trap different derivatives of the intermediates. Indeed, with radiolabeled nucleotide, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]-dUMP, we observed a previously unknown radioactive species, distinct from the acid-modified 5-hydroxymethyl-dUMP. The base-modified species was also observed with methylene-labeled folate, [11- S2B ), must have belonged to an adduct covalently linked to the trapped nucleotide. All FDTS mechanisms proposed heretofore (6-9) (e.g., fig. S3 ) postulate that the methylene is transferred directly from CH 2 H 4 fol to the nucleotide, as in the TSase reaction (10) , and the absorbance spectrum of the trapped intermediate ( fig. S4) fig. S5B ), indicating that the labeled dimethylbenzene portion of isoalloxazine ( fig. S5A ) was a part of the trapped species. Additionally, when we used FDTS containing FAD uniformly labeled with N at its dioxopyrimidine (ring "C" in fig. S5 ), that is, 6 daltons heavier than unlabeled FAD, the mass of the isolated trapped intermediate was heavier by only 2 daltons than that produced by the unlabeled enzyme ( fig. S2C ). This finding suggests that only two labeled atoms of the dioxopyrimidine ring of the flavin are retained in the base-modified intermediate.
Several nuclear magnetic resonance (NMR) experiments were performed to determine the structure of the base-trapped intermediate (Fig.  3, figs. S6 and S7, and table S2) . Critically, the methylene (U7) originating in the CH 2 H 4 fol had bonded to C5 of the dUMP moiety and coupled to FC5a and FC4a of the degraded flavin in the NMR heteronuclear multiple-bond correlation (HMBC) spectrum (Fig. 3) . These results and others presented in the supplementary materials show that CH 2 H 4 fol-derived methylene bridges dUMP and degraded flavin, connecting C5 of dUMP and N5 of the decomposed isoalloxazine moiety. Other structural features of the base-trapped intermediate derivative are described in the supplementary materials.
The presence of a covalent methylene bridge between dUMP and flavin indicates a previously unconsidered mechanism substantially different from earlier mechanisms (6, 7, 9) (fig. S3 ). This mechanism, given in Fig. 4 and fig. S8 , postulates that N5 of the reduced flavin accepts the activated methylene from the CH 2 H 4 fol Schiff base (step 1), and then passes it to C5 of the enzymepolarized dUMP (steps 2 and 3). This mechanism agrees well with crystal structures of FDTS complexes with FAD, dUMP, and folates [Protein Data Bank identifications (PDB IDs): 4GT9, 4GTA, and 4GTB], in which the isoalloxazine moiety of FAD is sandwiched between the folate ring and uracil (8) (Fig. 4) . Thus, whereas protein-bound flavins typically carry electrons from one side of the flavin ring to the other, the FAD of FDTS carries a methylene.
The proposed intermediates I 1 and I 2 are modified in base to the compound identified in Fig. 3 and product, respectively. However, both are converted to 5-hydroxymethyl-dUMP in acid. The mechanisms of their degradation are discussed in the supplementary materials and presented in fig. S10 .
Why wasn't such a mechanism considered when the structure of FDTS complex with its substrates was solved in 2012 (8)? The reason lies in reports of activity of FDTS reconstituted with 5-deaza-5-carba-FAD (henceforth 5-deaza-FAD) (7, 9) . In 5-deaza-FAD, N5 of the flavin has been replaced with a carbon, which prohibits several chemical conversions proposed in Fig. 4 . The identification of the base-modified intermediate prompted us to revisit this finding. We synthesized 5-deaza-FAD and incorporated it into apo-FDTS. In doing so, we found that the procedure used in the past for removing FAD from holo-TmFDTS (salting out) (4, 9) leaves behind variable amounts of FAD, producing the same level of (residual) activity in the salted-out "apoenzyme" as in 5-deaza-FADreconstituted FDTS. By denaturing the apoenzyme with 8 M urea after salting out, completely removing FAD, then refolding and reconstituting with either FAD or 5-deaza-FAD, we found no activity for the apoenzyme, fully recovered activity for FAD-reconstituted enzyme, and no activity for the enzyme reconstituted with 5-deaza-FAD ( fig. S9 ). This indicates that 5-deaza-FAD-FDTS is actually not active at all (<10 −6 at the signal/noise limit, see supplementary materials), removing the conceptual barrier for the mechanism proposed in Fig. 4 . C heteronuclear multiple-quantum coherence (black; red marks folded cross-peaks) and HMBC (green) spectra. The cross-peaks are labeled with the first letter representing the subunit (U or F). The cross-peaks of the HMBC spectrum circled in red unambiguously establish that the CH 2 H 4 fol-drived methylene (U7) bridges dUMP and flavin derivative. ppm, parts per million.
Flavin's N5-mediated methylene transfer might be rare, but it has been proposed for TrmFO tRNA methyltransferase (12) . However, in TrmFO the uracil is activated via Michael addition of activesite cysteine to C6 of the pyrimidine ring, and a second cysteine activates and delivers the methylene to the flavin. In FDTSs, no such enzymatic nucleophile is available (7), and the cause of the uracil's initial activation has been a matter of uncertainty. One hypothesis posits that the N5 hydride of reduced FAD nucleophilically activates dUMP (7) (fig. S3A ), whereas another suggests that the enzyme polarizes the pyrimidine ring of dUMP for an attack on the CH 2 H 4 fol methylene (6, 9) without a Michael nucleophile ( fig. S3B ). The latter chemistry is unprecedented in nucleotide methylation, and the need for pyrimidine activation via Michael addition to its C6 has been emphasized in enzymatic and nonenzymatic systems (6) . The only supporting pieces of evidence so far were the absence of deuterated trapped intermediates (6) and ultravioletvisible features consistent with those of reduced flavin [ Fig. 2, green trace, and (5, 9) ], but these observations can be rationalized by more conventional mechanisms (6) . Such nucleotide activation was thus met with healthy skepticism.
The current findings provide the strongest supporting evidence so far for pyrimidine activation via polarization in the reduced enzyme's active center. Because the methylene-carrier role for flavin's N5 proposed here (Fig. 4) requires FAD to be reduced during carbon transfer to dUMP, flavin oxidation during substrate activation ( fig. S3A ) can be definitively ruled out. The mechanism proposed in Fig. 4 also agrees with the observation (7) that, when the TmFDTS reaction is conducted in D 2 O at near-physiological temperatures, a deuterium is incorporated at C7 of the dTMP product while some deuterium is found at C6 of the product at low temperature ( fig. S8) .
The data presented above dictate a thymidylate biosynthesis mechanism (Fig. 4) in thyX-dependent human pathogens that is fundamentally different from that found in humans, lending hope for development of mechanism-based FDTS inhibitors as a new class of nontoxic antibiotics (see supplementary materials). fig. S10  and supplementary text) . The "420 nm absorbance" versus "colorless" labels of flavins relate the 420-nm time trace (green line in Fig. 2 ) to the mechanistic model. A rigorous electron-pushing description of this mechanism is presented in fig. S8 . R, 2′-deoxyribose-5′-phosphate; R′, (p-aminobenzoyl)glutamate; and R″, adenosine-5′-pyrophosphate-ribityl. (Right) Active site of FDTS [PDB ID 4GTA (8) ] in complex with FAD, dUMP, and folinic acid, a stable analog of the activated CH 2 H 4 fol. For clarity, the carbonyl oxygen of folinic acid is not shown, and the structure is inversed to match the orientation of ligands in the left-hand structures. The formyl carbon (magenta) on folinic acid represents the methylene to be transferred. Black arrows mark the methylene-transfer trajectory from donor (N5 of folate) to proposed relay atom (N5 of flavin) and final acceptor (C5 of dUMP).
